10.1021/jo301607a
The research focuses on the development of a convenient synthesis method for 1,2,3-thiadiazoles and 1,2,3-selenadiazoles, which are important heterocyclic compounds with broad pharmacological properties, including anticancer, antibacterial, and antifungal activities. The study utilizes an ionic liquid as a novel soluble support, offering a simple and efficient approach to synthesize these compounds. The methodology involves the synthesis of ionic liquid-supported sulfonyl hydrazine, which is then reacted with various ketones and 1,2-diketones to form ionic liquid-supported hydrazones. These hydrazones are subsequently converted to 1,2,3-thiadiazoles in the presence of thionyl chloride, while 1,2,3-selenadiazoles are obtained by reacting the hydrazones with selenium dioxide in acetonitrile. The research concludes that this approach offers several advantages, such as ease of workup, simple reaction conditions, and high purity of the products. The chemicals used in the process include 1-methylimidazole, 1,4-butane sultone, trifluoromethane sulfonic acid (TfOH), thionyl chloride, hydrazine hydrate, and various ketones and 1,2-diketones, as well as selenium dioxide for the synthesis of selenadiazoles.